Product image of Bortezomib Accord (Bortezomib) supplied by GNH India

Bortezomib Accord

Active Ingredient:
Bortezomib
Origin:
EU

Bortezomib Accord (Bortezomib)

Bortezomib Accord is a pharmaceutical product used for intravenous administration. It belongs to a class of drugs known as proteasome inhibitors, often utilized in specific medical treatments.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Bortezomib is primarily used in the treatment of certain types of cancer, particularly multiple myeloma and mantle cell lymphoma. It works by inhibiting the proteasome, a complex within cells that breaks down proteins. This action can help to slow the growth of cancer cells. Patients often wonder, 'What is Bortezomib used for?' and the answer lies in its role as a proteasome inhibitor in cancer therapy.

Side Effects

  • Common effects of Bortezomib may include fatigue, nausea, and peripheral neuropathy. Some patients may experience diarrhea or constipation. These effects can vary widely among individuals and are not exhaustive. Always consult a healthcare provider for personalized information.

Precautions & Warnings

  • Bortezomib should be handled with care, as it is intended for intravenous use. It is important to follow proper administration procedures to minimize the risk of infection or other complications. Patients with a history of certain conditions should discuss their medical history with a healthcare provider before use.

Avoid Interactions

  • Bortezomib may interact with other medications, including those that affect the liver or immune system. Alcohol and certain over-the-counter drugs may also interact with Bortezomib. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Bortezomib is used in the treatment of certain types of cancer, such as multiple myeloma and mantle cell lymphoma.

Bortezomib is administered intravenously, typically by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, and peripheral neuropathy. Always consult a healthcare provider for detailed information.

Bortezomib may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Bortezomib Accord is manufactured by Accord Healthcare S.L.U., a reputable pharmaceutical company.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bortezomib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT